


国际肿瘤学杂志››2025,Vol. 52››Issue (7): 401-408.doi:10.3760/cma.j.cn371439-20250123-00070
收稿日期:2025-01-23修回日期:2025-06-16出版日期:2025-07-08发布日期:2025-07-23通讯作者:吴凡 E-mail:13791080608@139.com基金资助:
Liu Qi1, Qu Guobin2, Zhu Jian1,3, Wu Fan4(
)
Received:2025-01-23Revised:2025-06-16Online:2025-07-08Published:2025-07-23Contact:Wu Fan E-mail:13791080608@139.comSupported by:
摘要:
目的系统评估双能CT(DECT)中虚拟平扫(VNC)图像与真实平扫(TNC)图像在CT值上的差异,并验证VNC图像在光子、质子放疗计划剂量计算中替代TNC图像的可行性。方法回顾性分析2022年2月至2023年5月于百度开云体育app附属肿瘤医院接受DECT检查的40例实体瘤患者(头颅20例,胸、腹部各10例)的影像数据。对VNC与TNC图像逐层配准,并比较不同解剖结构的CT值差异,采用Pearson相关分析评估VNC与TNC图像中不同解剖结构CT值的相关性。对差异显著的结构采用最小二乘法建立回归模型(TNC=βVNC+α)。在Eclipse 15.5放疗计划系统中分别设计基于TNC图像与VNC图像的光子与质子放疗计划,以及基于回归模型校正后VNC图像的质子放疗计划,评估两种图像放疗计划的剂量差异。为评估临床靶区(CTV)邻近区域的剂量变化,于CTV所在轴向最大层面分别向前(头侧)和向后(足侧)方向构建厚度为2 mm的环形参照结构,分别命名为Ring_p与Ring_d。结果VNC与TNC图像的CT值差异主要集中于骨性结构,20例颅脑肿瘤患者的颅骨CT值差异为(409.07±53.38)HU(t=13.88,P<0.001),10例胸部和10例腹部肿瘤患者的脊椎骨CT值差异为(118.66±20.90)HU(t=10.43,P<0.001)。TNC与VNC图像的颅骨(r=0.98,P<0.001)和脊椎骨(r=0.99,P<0.001)CT值均高度相关,分别建立回归模型为:TNC=1.859×VNC+33.896和TNC=1.827×VNC+5.491。基于TNC图像与VNC图像设计的光子放疗计划中,CTV的Dmean分别为(60.00±0.00)与(60.00±0.00)Gy,Ring_p的Dmean分别为(61.17±1.69)与(61.01±1.67)Gy,Ring_d的Dmean分别为(55.26±2.06)与(55.20±1.94)Gy,两组间Dmean的相对剂量差分别为0(t<0.01,P>0.999)、0.33%(t=0.30,P=0.766)和0.19%(t=0.07,P=0.947),差异均无统计学意义。基于TNC图像与VNC图像设计的质子放疗计划中,CTV的Dmean分别为(61.73±0.32)与(61.67±0.26)Gy(RBE),Ring_p的Dmean分别为(61.19±0.44)与(60.53±1.22)Gy(RBE),Ring_d的Dmean分别为(60.97±0.67)与(59.80±4.26)Gy(RBE),两组间Dmean的相对剂量差分别为0.24%(t=0.63,P=0.530)、1.80%(t=1.45,P=0.156)、3.56%(t=2.26,P=0.030),其中Ring_d区域差异有统计学意义。基于校正后VNC图像设计的质子放疗计划中,CTV的Dmean为(61.75±0.32)Gy(RBE),Ring_p的Dmean为(61.43±0.71)Gy(RBE),Ring_d的Dmean为(59.96±2.80)Gy(RBE),基于TNC与校正后VNC图像间Dmean的相对剂量差分别为0.16%(t=0.19,P=0.850)、0.76%(t=1.32,P=0.196)和2.22%(t=1.93,P=0.061),差异均无统计学意义。结论DECT中VNC与TNC图像的CT值差异主要存在于骨性结构,尤其是颅骨和脊椎骨。对于颅脑肿瘤患者,VNC图像可以直接用于光子放疗计划;而在质子放疗中,VNC图像经回归模型校正后,可有效替代TNC图像用于放疗计划剂量计算。
刘琦, 曲国斌, 朱健, 吴凡. 双能CT虚拟平扫图像代替真实平扫图像在光子与质子放疗剂量计算中的可行性研究[J]. 国际肿瘤学杂志, 2025, 52(7): 401-408.
Liu Qi, Qu Guobin, Zhu Jian, Wu Fan. Feasibility study of using dual-energy CT virtual non-contrast images to replace true non-contrast images in photon and proton radiotherapy dose calculations[J]. Journal of International Oncology, 2025, 52(7): 401-408.
表1
40例实体瘤患者DECT扫描TNC与VNC图像中颅骨与脊椎骨的平均CT值(HU)"
| 患者 | VNC | TNC | 患者 | VNC | TNC | 患者 | VNC | TNC | 患者 | VNC | TNC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 421.7 | 870.7 | 11 | 479.1 | 912.6 | 21 | 155.2 | 289.9 | 31 | 128.9 | 242.9 |
| 2 | 434.9 | 845.1 | 12 | 479.3 | 927.1 | 22 | 126.1 | 230.8 | 32 | 157.0 | 299.0 |
| 3 | 482.2 | 957.1 | 13 | 467.9 | 886.2 | 23 | 138.2 | 256.5 | 33 | 132.9 | 254.0 |
| 4 | 439.3 | 821.6 | 14 | 428.0 | 834.3 | 24 | 146.4 | 271.7 | 34 | 116.5 | 222.2 |
| 5 | 426.8 | 817.4 | 15 | 338.9 | 652.9 | 25 | 190.9 | 359.2 | 35 | 141.3 | 253.0 |
| 6 | 329.5 | 649.6 | 16 | 453.1 | 886.6 | 26 | 107.3 | 201.0 | 36 | 142.3 | 268.6 |
| 7 | 471.7 | 874.3 | 17 | 476.4 | 915.1 | 27 | 135.7 | 242.8 | 37 | 149.4 | 269.9 |
| 8 | 442.6 | 842.5 | 18 | 500.2 | 991.7 | 28 | 99.3 | 184.0 | 38 | 121.6 | 234.1 |
| 9 | 548.5 | 1 053.2 | 19 | 338.2 | 646.0 | 29 | 169.4 | 306.9 | 39 | 138.2 | 264.4 |
| 10 | 379.4 | 726.3 | 20 | 341.0 | 681.8 | 30 | 156.8 | 297.4 | 40 | 85.5 | 163.5 |
表2
20例颅脑肿瘤患者基于VNC与TNC图像设计的光子放疗计划CTV、Ring_p和Ring_d的Dmean(Gy)"
| 患者 | VNC | TNC | |||||
|---|---|---|---|---|---|---|---|
| CTV | Ring_p | Ring_d | CTV | Ring_p | Ring_d | ||
| 1 | 60.00 | 61.44 | 55.03 | 60.00 | 61.66 | 55.02 | |
| 2 | 60.00 | 62.32 | 54.78 | 60.00 | 62.38 | 54.82 | |
| 3 | 60.00 | 61.81 | 55.03 | 60.00 | 61.82 | 55.02 | |
| 4 | 60.00 | 61.15 | 56.14 | 60.00 | 61.16 | 56.07 | |
| 5 | 60.00 | 59.55 | 54.56 | 60.00 | 59.70 | 54.58 | |
| 6 | 60.00 | 60.83 | 55.32 | 60.00 | 61.02 | 55.33 | |
| 7 | 60.00 | 60.46 | 54.56 | 60.00 | 60.64 | 54.61 | |
| 8 | 60.00 | 61.34 | 54.10 | 60.00 | 61.35 | 53.98 | |
| 9 | 60.00 | 59.85 | 54.58 | 60.00 | 59.84 | 54.55 | |
| 10 | 60.00 | 63.12 | 55.51 | 60.00 | 62.96 | 55.60 | |
| 11 | 60.00 | 55.57 | 62.93 | 60.00 | 55.43 | 63.57 | |
| 12 | 60.00 | 62.63 | 54.53 | 60.00 | 62.83 | 54.49 | |
| 13 | 60.00 | 59.97 | 53.26 | 60.00 | 60.20 | 53.24 | |
| 14 | 60.00 | 63.51 | 54.43 | 60.00 | 63.67 | 54.36 | |
| 15 | 60.00 | 60.94 | 55.13 | 60.00 | 60.78 | 54.98 | |
| 16 | 60.00 | 61.40 | 55.01 | 60.00 | 61.50 | 55.03 | |
| 17 | 60.00 | 60.58 | 55.37 | 60.00 | 60.95 | 55.30 | |
| 18 | 60.00 | 62.15 | 55.68 | 60.00 | 62.27 | 55.67 | |
| 19 | 60.00 | 60.29 | 53.54 | 60.00 | 61.67 | 54.19 | |
| 20 | 60.00 | 61.34 | 54.89 | 60.00 | 61.61 | 54.82 | |
表3
20例颅脑肿瘤患者基于VNC、TNC与矫正后VNC图像设计的质子放疗计划的CTV、Ring_p和Ring_d的Dmean[Gy(RBE)]"
| 患者 | VNC | TNC | 校正后VNC | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CTV | Ring_p | Ring_d | CTV | Ring_p | Ring_d | CTV | Ring_p | Ring_d | |||
| 1 | 61.44 | 60.35 | 61.49 | 61.49 | 60.99 | 60.91 | 61.66 | 61.41 | 60.89 | ||
| 2 | 61.34 | 62.10 | 60.53 | 62.11 | 61.29 | 61.98 | 61.73 | 62.43 | 60.73 | ||
| 3 | 61.52 | 61.82 | 61.06 | 61.54 | 61.89 | 61.17 | 61.67 | 62.24 | 59.68 | ||
| 4 | 62.06 | 59.29 | 62.41 | 62.29 | 61.01 | 61.60 | 62.34 | 60.79 | 62.15 | ||
| 5 | 62.03 | 59.48 | 61.65 | 62.08 | 61.51 | 59.99 | 62.17 | 61.04 | 60.85 | ||
| 6 | 61.58 | 60.64 | 61.54 | 61.63 | 61.40 | 61.35 | 61.66 | 61.21 | 61.34 | ||
| 7 | 61.66 | 62.22 | 47.70 | 60.92 | 60.64 | 59.75 | 61.00 | 62.47 | 50.93 | ||
| 8 | 61.34 | 61.75 | 59.46 | 61.50 | 61.60 | 60.90 | 61.46 | 61.91 | 60.48 | ||
| 9 | 61.61 | 61.26 | 61.76 | 61.59 | 61.23 | 61.88 | 61.85 | 62.07 | 60.15 | ||
| 10 | 61.68 | 60.32 | 61.68 | 61.77 | 61.09 | 61.66 | 61.76 | 60.85 | 61.85 | ||
| 11 | 61.02 | 58.52 | 61.12 | 61.11 | 60.43 | 60.24 | 61.19 | 60.14 | 60.64 | ||
| 12 | 61.79 | 62.19 | 51.19 | 61.70 | 61.44 | 60.26 | 61.68 | 62.23 | 54.09 | ||
| 13 | 61.75 | 59.37 | 61.94 | 61.80 | 61.24 | 61.49 | 61.81 | 61.00 | 61.65 | ||
| 14 | 61.68 | 62.21 | 51.60 | 61.70 | 61.05 | 60.56 | 61.36 | 62.23 | 57.20 | ||
| 15 | 61.96 | 60.57 | 61.84 | 61.99 | 61.84 | 60.73 | 62.03 | 61.72 | 60.93 | ||
| 16 | 61.82 | 59.59 | 61.53 | 61.87 | 60.85 | 60.07 | 61.89 | 60.72 | 60.36 | ||
| 17 | 61.76 | 59.69 | 61.83 | 61.88 | 60.92 | 60.98 | 61.93 | 61.10 | 60.78 | ||
| 18 | 61.67 | 58.52 | 62.10 | 61.80 | 60.31 | 61.50 | 61.80 | 60.33 | 61.57 | ||
| 19 | 61.94 | 60.45 | 62.12 | 61.98 | 61.78 | 61.67 | 62.07 | 61.57 | 61.96 | ||
| 20 | 61.81 | 60.32 | 61.49 | 61.88 | 61.23 | 60.80 | 61.96 | 61.16 | 61.04 | ||
| [1] | Caschera L, Lazzara A, Piergallini L, et al. Contrast agents in diagnostic imaging: present and future[J].Pharmacol Res,2016,110: 65-75. DOI:10.1016/j.phrs.2016.04.023. pmid:27168225 |
| [2] | Noid G, Zhu J, Tai A, et al. Improving structure delineation for radiation therapy planning using dual-energy CT[J].Front Oncol,2020,10: 1694. DOI:10.3389/fonc.2020.01694. pmid:32984048 |
| [3] | Jamali S, Michoux N, Coche E, et al. Virtual unenhanced phase with spectral dual-energy CT: is it an alternative to conventional true unenhanced phase for abdominal tissues?[J].Diagn Interv Imaging,2019,100(9): 503-511. DOI:10.1016/j.diii.2019.04.007. |
| [4] | Sauter AP, Muenzel D, Dangelmaier J, et al. Dual-layer spectral computed tomography: virtual non-contrast in comparison to true non-contrast images[J].Eur J Radiol,2018,104: 108-114. DOI:10.1016/j.ejrad.2018.05.007. pmid:29857855 |
| [5] | Ding Y, Richter A, Stiller W, et al. Association between true non-contrast and virtual non-contrast vertebral bone CT attenuation values determined using dual-layer spectral detector CT[J].Eur J Radiol,2019,121: 108740. DOI:10.1016/j.ejrad.2019.108740. |
| [6] | Ananthakrishnan L, Rajiah P, Ahn R, et al. Spectral detector CT-derived virtual non-contrast images: comparison of attenuation values with unenhanced CT[J].Abdom Radiol (NY),2017,42(3): 702-709. DOI:10.1007/s00261-016-1036-9. pmid:28084546 |
| [7] | Zopfs D, Lennartz S, Zaeske C, et al. Phantomless assessment of volumetric bone mineral density using virtual non-contrast images from spectral detector computed tomography[J].Br J Radiol,2020,93(1109): 20190992. DOI:10.1259/bjr.20190992. |
| [8] | Tran DN, Straka M, Roos JE, et al. Dual-energy CT discrimination of Iodine and calcium: experimental results and implications for lower extremity CT angiography[J].Acad Radiol,2009,16(2): 160-171. DOI:10.1016/j.acra.2008.09.004. pmid:19124101 |
| [9] | Noid G, Schott D, Paulson E, et al. Technical note: using virtual noncontrast images from dual-energy CT to eliminate the need of precontrast CT for x-ray radiation treatment planning of abdominal tumors[J].Med Phys,2021,48(3): 1365-1371. DOI:10.1002/mp.14702. pmid:33386614 |
| [10] | Civinini C, Scaringella M, Brianzi M, et al. Relative stopping power measurements and prosthesis artifacts reduction in proton CT[J].Phys Med Biol,2020,65(22): 225012. DOI:10.1088/1361-6560/abb0c8. |
| [11] | Chang CW, Gao Y, Wang T, et al. Dual-energy CT based mass density and relative stopping power estimation for proton therapy using physics-informed deep learning[J].Phys Med Biol,2022,67(11): 10. DOI:10.1088/1361-6560/ac6ebc. |
| [12] | Wen D, Pu Q, Peng P, et al. Comparison of virtual and true non-contrast images from dual-layer spectral detector computed tomography (CT) in patients with colorectal cancer[J].Quant Imaging Med Surg,2024,14(9): 6260-6272. DOI:10.21037/qims-24-535. |
| [1] | 朱健.肿瘤质子放疗剂量学特点序言[J]. 国际肿瘤学杂志, 2025, 52(7): 432-433. |
| [2] | 吴仕章, 胡漫, 戴天缘, 李成强, 陶城, 段敬豪, 陈进琥, 白曈, 孔甜, 朱健.全中枢神经系统肿瘤1例质子放疗剂量学特点分析[J]. 国际肿瘤学杂志, 2025, 52(7): 434-440. |
| [3] | 徐渐, 段敬豪, 刘庆增, 朱健.脊索瘤质子放疗中能谱CT参数与MRI ADC变化的相关性研究[J]. 国际肿瘤学杂志, 2025, 52(7): 441-447. |
| [4] | 李成强, 王云刚, 余以珊, 吴仕章, 陶城, 马星民, 戴天缘, 段敬豪, 陈进琥, 白曈, 朱健.乳腺癌4例质子放疗剂量学特点分析[J]. 国际肿瘤学杂志, 2025, 52(7): 448-454. |
| [5] | 段敬豪, 岳金波, 陶城, 吴仕章, 李成强, 戴天缘, 陈进琥, 白曈, 朱健.腹盆部肿瘤3例质子放疗剂量学特点分析[J]. 国际肿瘤学杂志, 2025, 52(7): 455-461. |
| [6] | 钟啸, 李步托, 王琳琳.ALK阳性NSCLC脑转移放疗的研究进展[J]. 国际肿瘤学杂志, 2025, 52(6): 374-378. |
| [7] | 吕晓岩, 王媛, 王军.精准医学背景下的食管鳞状细胞癌放疗研究进展[J]. 国际肿瘤学杂志, 2025, 52(5): 268-272. |
| [8] | 文英美, 夏锦雄, 王园园, 姚颐.放疗对抗肿瘤免疫的影响:从基础到临床[J]. 国际肿瘤学杂志, 2025, 52(4): 231-236. |
| [9] | 中华医学会放射肿瘤治疗学分会, 中国医师协会放射肿瘤治疗医师分会, 中国抗癌协会肿瘤放射治疗专业委员会.中国食管癌放射治疗指南(2024年版)[J]. 国际肿瘤学杂志, 2025, 52(1): 3-22. |
| [10] | 吴晓维, 胡格, 陈莉, 钱晓涛, 崔相利, 朱凤琴.放疗前肿瘤最大径、外周血NLR对食管鳞状细胞癌患者放疗后发生食管瘘的预测价值[J]. 国际肿瘤学杂志, 2025, 52(1): 38-42. |
| [11] | 付成瑞, 李宝生, 黄伟.食管癌质子放疗研究进展[J]. 国际肿瘤学杂志, 2025, 52(1): 48-52. |
| [12] | 尹浩, 吴旭栋, 王磊.螺旋断层放疗治疗食管癌的临床疗效及安全性分析[J]. 国际肿瘤学杂志, 2024, 51(9): 578-584. |
| [13] | 吕俊, 熊昊, 郑燕秋, 董礼.非小细胞肺癌患者放疗后肺部侵袭性真菌病发生危险因素及预测模型构建[J]. 国际肿瘤学杂志, 2024, 51(8): 493-497. |
| [14] | 于新生, 任磊, 卢晓光.现代质子放疗和光子放疗的争论与思考[J]. 国际肿瘤学杂志, 2024, 51(7): 411-416. |
| [15] | 孔琳, 陆嘉德.突破与挑战:恶性肿瘤质子重离子放疗的临床应用与进展[J]. 国际肿瘤学杂志, 2024, 51(7): 417-423. |
| 阅读次数 | ||||||
| 全文 |
|
|||||
| 摘要 |
|
|||||